Literature DB >> 26518435

Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia.

Valerie Tutwiler1, Daria Madeeva2, Hyun Sook Ahn2, Izabella Andrianova3, Vincent Hayes2, X Long Zheng4, Douglas B Cines5, Steven E McKenzie6, Mortimer Poncz7, Lubica Rauova7.   

Abstract

Heparin-induced thrombocytopenia (HIT) is characterized by a high incidence of thrombosis, unlike other antibody-mediated causes of thrombocytopenia. We have shown that monocytes complexed with surface-bound platelet factor 4 (PF4) activated by HIT antibodies contribute to the prothrombotic state in vivo, but the mechanism by which this occurs and the relationship to the requirement for platelet activation via fragment crystallizable (Fc)γRIIA is uncertain. Using a microfluidic model and human or murine blood, we confirmed that activation of monocytes contributes to the prothrombotic state in HIT and showed that HIT antibodies bind to monocyte FcγRIIA, which activates spleen tyrosine kinase and leads to the generation of tissue factor (TF) and thrombin. The combination of direct platelet activation by HIT immune complexes through FcγRIIA and transactivation by monocyte-derived thrombin markedly increases Annexin V and factor Xa binding to platelets, consistent with the formation of procoagulant coated platelets. These data provide a model of HIT wherein a combination of direct FcγRIIA-mediated platelet activation and monocyte-derived thrombin contributes to thrombosis in HIT and identifies potential new targets for lessening this risk.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26518435      PMCID: PMC4731847          DOI: 10.1182/blood-2013-11-539262

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

1.  Simultaneous engagement of thrombin and Fc gamma RIIA receptors results in platelets expressing high levels of procoagulant proteins.

Authors:  P Batar; G L Dale
Journal:  J Lab Clin Med       Date:  2001-12

2.  Hemodynamic shear stress and its role in atherosclerosis.

Authors:  A M Malek; S L Alper; S Izumo
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

3.  Heparin-induced thrombocytopenia: effects of rabbit IgG, and its Fab and FC fragments on antibody-heparin-platelet interaction.

Authors:  B H Chong; P A Castaldi; M C Berndt
Journal:  Thromb Res       Date:  1989-07-15       Impact factor: 3.944

4.  The human mononuclear phagocyte high-affinity Fc receptor, FcRI, defined by a monoclonal antibody, 10.1.

Authors:  G J Dougherty; Y Selvendran; S Murdoch; D G Palmer; N Hogg
Journal:  Eur J Immunol       Date:  1987-10       Impact factor: 5.532

5.  Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8.

Authors:  G M Arepally; I M Mayer
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

6.  Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range.

Authors:  A Greinacher; P Eichler; N Lubenow; H Kwasny; M Luz
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

7.  Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcgammaRIIA.

Authors:  M P Reilly; S M Taylor; N K Hartman; G M Arepally; B S Sachais; D B Cines; M Poncz; S E McKenzie
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

8.  Characterization of a heparan sulfate and a peculiar chondroitin 4-sulfate proteoglycan from platelets. Inhibition of the aggregation process by platelet chondroitin sulfate proteoglycan.

Authors:  H B Nader
Journal:  J Biol Chem       Date:  1991-06-05       Impact factor: 5.157

9.  Heparin-induced thrombocytopenia: laboratory studies.

Authors:  J G Kelton; D Sheridan; A Santos; J Smith; K Steeves; C Smith; C Brown; W G Murphy
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

10.  Immune endothelial-cell injury in heparin-associated thrombocytopenia.

Authors:  D B Cines; A Tomaski; S Tannenbaum
Journal:  N Engl J Med       Date:  1987-03-05       Impact factor: 91.245

View more
  33 in total

Review 1.  Drug-associated thrombocytopenia.

Authors:  Tamam Bakchoul; Irene Marini
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Neutrophil accumulation and NET release contribute to thrombosis in HIT.

Authors:  Kandace Gollomp; Minna Kim; Ian Johnston; Vincent Hayes; John Welsh; Gowthami M Arepally; Mark Kahn; Michele P Lambert; Adam Cuker; Douglas B Cines; Lubica Rauova; M Anna Kowalska; Mortimer Poncz
Journal:  JCI Insight       Date:  2018-09-20

3.  Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia.

Authors:  Vincent Hayes; Ian Johnston; Gowthami M Arepally; Steven E McKenzie; Douglas B Cines; Lubica Rauova; Mortimer Poncz
Journal:  J Clin Invest       Date:  2017-02-20       Impact factor: 14.808

4.  Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia.

Authors:  Douglas B Cines; Serge V Yarovoi; Sergei V Zaitsev; Tatiana Lebedeva; Lubica Rauova; Mortimer Poncz; Gowthami M Arepally; Sanjay Khandelwal; Victoria Stepanova; Ann H Rux; Adam Cuker; Cecilia Guo; Linnette Mae Ocariza; Richard J Travers; Stephanie A Smith; Hugh Kim; James H Morrissey; Edward M Conway
Journal:  Blood Adv       Date:  2016-11-22

5.  Infused factor VIII-expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A.

Authors:  Randolph B Lyde; Hyun Sook Ahn; Karen K Vo; Danuta J Jarocha; John Tkaczynski; Elsa Treffeisen; Spencer K Sullivan; Rodney M Camire; Denise E Sabatino; Deborah L French; Mortimer Poncz
Journal:  Blood Adv       Date:  2019-05-14

6.  Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT?

Authors:  Luise Goldmann; Rundan Duan; Thorsten Kragh; Georg Wittmann; Christian Weber; Reinhard Lorenz; Philipp von Hundelshausen; Michael Spannagl; Wolfgang Siess
Journal:  Blood Adv       Date:  2019-12-10

Review 7.  Heparin-induced thrombocytopenia.

Authors:  Gowthami M Arepally
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

Review 8.  Heparin-induced thrombocytopenia: research and clinical updates.

Authors:  Oluwatoyosi Onwuemene; Gowthami M Arepally
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 9.  Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients.

Authors:  Daniela R Junqueira; Liliane M Zorzela; Edson Perini
Journal:  Cochrane Database Syst Rev       Date:  2017-04-21

Review 10.  Atomic features of an autoantigen in heparin-induced thrombocytopenia (HIT).

Authors:  Zheng Cai; Zhiqiang Zhu; Mark I Greene; Douglas B Cines
Journal:  Autoimmun Rev       Date:  2016-03-09       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.